BioInvent
Business Services · Sweden · 51-200 Employees
View Company Info for Free
Overview
Headquarters
Molekylvägen 2, Lund, Skane, 223 70, Swe...Phone Number
+46 462868550Website
www.bioinvent.comRevenue
$16.1 MillionStock Symbol
BINVIndustry
About BioInvent
BioInvent Org Chart
Partner - Patent Attorney
Is BioInvent your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Funding: Get notified immidiatlly once BioInvent has new funding data
Check if BioInvent has recently received funding, and reach out quickly before it becomes old news!
Earning: See what the market has to say on BioInvent recently announced quarterly report
Congratulate Masked Content for being promoted to Masked Content at BioInvent
Product Launch: Get notified when BioInvent launches new products
Website visits: Recent activity has been detected on your website
Check out if BioInvent is spiking on competitors!
BioInvent, which may be a good buyer, showed buying intent in Masked Content Topic
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Click to see if BioInvent had a recent Job posting/layoffs
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 2 more new buyers
Company Profile Activity
Activity Insights
BioInvent is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
BioInvent is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about BioInvent.
BioInvent Tech Stack
A closer look at the technologies used by BioInvent
Most Recent Scoops
BioInvent News & Media
BioInvent (OM:BINV) Forecasts 57% Annual Earnings Growth, Challenging Persistent Loss Narrative
BioInvent International (OM:BINV) remains unprofitable, with net losses having expanded at a pace of 27.2% per year over the past five years and no improvement in profit margins during that period. Still, revenue is forecast to grow by 22.6% per year and earnings are expected to accelerate by 57.17% per year. The company is projected to achieve profitability within the next three years, outpacing broader Swedish market metrics. Investors may view this combination of substantialBioInvent International AB (publ) (BOVNF) Q3 2025 Earnings Call Transcript
BioInvent International AB (publ) (OTCPK:BOVNF) Q3 2025 Earnings Call October 29, 2025 9:00 AM EDTCompany ParticipantsMartin Welschof - President &...Transgene and BioInvent’s Armed Oncolytic Virus BT-001 Shows Positive Local, Abscopal, and Sustained Antitumoral Activity in Advanced Refractory Tumors
BT-001 in combination with pembrolizumab is well tolerated and shows sustained antitumoral activity in both injected and non-injected lesions
Top Business Services Companies
Frequently Asked Questions Regarding BioInvent
Headquartered in Lund, Sweden, BioInvent is a clinical-stage biotech company that discovers and develops novel and first-in-class immuno-modulatory antibodies for cancer therapy.... Read More